These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 19638546)

  • 1. Appropriateness of antineutrophil cytoplasmic antibody testing in a tertiary hospital.
    Robinson PC; Steele RH
    J Clin Pathol; 2009 Aug; 62(8):743-5. PubMed ID: 19638546
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Antineutrophil cytoplasmic antibody (ANCA) testing: Audit from a clinical immunology laboratory.
    Phatak S; Aggarwal A; Agarwal V; Lawrence A; Misra R
    Int J Rheum Dis; 2017 Jun; 20(6):774-778. PubMed ID: 27457216
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Role of antineutrophil cytoplasmic antibodies and glomerular basement membrane antibodies in the diagnosis and monitoring of systemic vasculitides.
    Sinclair D; Stevens JM
    Ann Clin Biochem; 2007 Sep; 44(Pt 5):432-42. PubMed ID: 17761028
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Using antineutrophil cytoplasmic antibody testing to diagnose vasculitis: can test-ordering guidelines improve diagnostic accuracy?
    Mandl LA; Solomon DH; Smith EL; Lew RA; Katz JN; Shmerling RH
    Arch Intern Med; 2002 Jul; 162(13):1509-14. PubMed ID: 12090888
    [TBL] [Abstract][Full Text] [Related]  

  • 5. What do antineutrophil cytoplasmic antibodies (ANCA) tell us?
    Savige J; Pollock W; Trevisin M
    Best Pract Res Clin Rheumatol; 2005 Apr; 19(2):263-76. PubMed ID: 15857795
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Does a gating policy for ANCA overlook patients with ANCA associated vasculitis? An audit of 263 patients.
    Arnold DF; Timms A; Luqmani R; Misbah SA
    J Clin Pathol; 2010 Aug; 63(8):678-80. PubMed ID: 20702467
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Infective endocarditis by Bartonella quintana masquerading as antineutrophil cytoplasmic antibody-associated small vessel vasculitis.
    Sugiyama H; Sahara M; Imai Y; Ono M; Okamoto K; Kikuchi K; Nagai R
    Cardiology; 2009; 114(3):208-11. PubMed ID: 19602882
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The CARI guidelines. ANCA serology in the diagnosis and management of ANCA-associated renal vasculitis.
    Luxton G; Langham R;
    Nephrology (Carlton); 2008 Jul; 13 Suppl 2():S17-23. PubMed ID: 18713120
    [No Abstract]   [Full Text] [Related]  

  • 9. A novel enzyme-linked immunosorbent assay using a mixture of human native and recombinant proteinase-3 significantly improves the diagnostic potential for antineutrophil cytoplasmic antibody-associated vasculitis.
    Damoiseaux J; Dähnrich C; Rosemann A; Probst C; Komorowski L; Stegeman CA; Egerer K; Hiepe F; van Paassen P; Stöcker W; Schlumberger W; Tervaert JW
    Ann Rheum Dis; 2009 Feb; 68(2):228-33. PubMed ID: 18375539
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The effect of a symptom related "gating policy" on ANCA requests in routine clinical practice.
    Sinclair D; Saas M; Stevens JM
    J Clin Pathol; 2004 Feb; 57(2):131-4. PubMed ID: 14747434
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antineutrophil cytoplasmic antibody (ANCA) testing of routine sera varies in different laboratories but concordance is greater for cytoplasmic fluorescence (C-ANCA) and myeloperoxidase specificity (MPO-ANCA).
    Pollock W; Jovanovich S; Savige J
    J Immunol Methods; 2009 Aug; 347(1-2):19-23. PubMed ID: 19490915
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Most proteinase3- and myeloperoxidase-antineutrophil cytoplasmic antibodies enzyme-linked immunosorbent assays perform less well in treated small-vessel vasculitis than in active disease.
    Savige J; Trevisin M; Hayman M; Pollock W
    APMIS Suppl; 2009 Jun; (127):60-2. PubMed ID: 19515142
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Addendum to the International Consensus Statement on testing and reporting of antineutrophil cytoplasmic antibodies. Quality control guidelines, comments, and recommendations for testing in other autoimmune diseases.
    Savige J; Dimech W; Fritzler M; Goeken J; Hagen EC; Jennette JC; McEvoy R; Pusey C; Pollock W; Trevisin M; Wiik A; Wong R;
    Am J Clin Pathol; 2003 Sep; 120(3):312-8. PubMed ID: 14502794
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Determination of anti-neutrophil cytoplasmic antibodies in small vessel vasculitis: Comparative analysis of different strategies.
    Vermeersch P; Vervaeke S; Blockmans D; van Hoovels L; Mariën G; Vanmaele H; Bossuyt X
    Clin Chim Acta; 2008 Nov; 397(1-2):77-81. PubMed ID: 18708041
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Smoking habits in patients diagnosed with ANCA associated small vessel vasculitis.
    Haubitz M; Woywodt A; de Groot K; Haller H; Goebel U
    Ann Rheum Dis; 2005 Oct; 64(10):1500-2. PubMed ID: 16162902
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Evaluation of a multiplex flow cytometric immunoassay to detect PR3- and MPO-ANCA in active and treated vasculitis, and in inflammatory bowel disease (IBD).
    Trevisin M; Pollock W; Dimech W; Savige J
    J Immunol Methods; 2008 Jul; 336(2):104-12. PubMed ID: 18499121
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The CARI guidelines. Induction and maintenance therapy in ANCA-associated systemic vasculitis.
    Menahem S; Hiremagalur B; Mudge D; Toussaint N; Walters G;
    Nephrology (Carlton); 2008 Jul; 13 Suppl 2():S24-36. PubMed ID: 18713121
    [No Abstract]   [Full Text] [Related]  

  • 18. Immunologic markers as potential predictors of systemic autoimmune disease in patients with idiopathic scleritis.
    Lin P; Bhullar SS; Tessler HH; Goldstein DA
    Am J Ophthalmol; 2008 Mar; 145(3):463-471. PubMed ID: 18061135
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diagnostic outcome and indications for testing in patients with positive ANCA at a Canadian tertiary care centre.
    Chehroudi C; Booth RA; Milman N
    Rheumatol Int; 2018 Apr; 38(4):641-647. PubMed ID: 29243051
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Antineutrophil cytoplasmic antibody measurement: advantages and disadvantages of a capture PR3 ELISA and a direct PR3 ELISA.
    O'Donnell JL; Hayman MW; Spellerberg MB; McLellan AD; Brooksbank K; Chapman PT; Stamp LK
    Pathology; 2007 Apr; 39(2):258-63. PubMed ID: 17454758
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.